Other Vaccines - United Arab Emirates

United Arab Emirates

Highlights

The revenue in the Other Vaccines market is estimated to reach US$91.47m in 2024.
It is anticipated that the revenue will exhibit an annual growth rate (CAGR 2024-2029) of 11.52%, leading to a market volume of US$157.80m by 2029.
When compared globally, United States is projected to generate the highest revenue in this market, amounting to US$24.73bn in 2024.
The United Arab Emirates is experiencing a growing demand for other vaccines, driven by the government's focus on public health and disease prevention.

Key regions:

Market definitionIn-Scope/Out-of-scopeMarket structureReportsMethodology

The Other Vaccines market in United Arab Emirates has been experiencing significant growth in recent years.

Customer preferences: Customers in United Arab Emirates have been increasingly interested in preventative healthcare measures, including vaccinations. This is due to a growing awareness of the importance of maintaining good health, as well as an increasing focus on the prevention of communicable diseases.

Trends in the market: One of the major trends in the Other Vaccines market in United Arab Emirates is the growing demand for vaccines that protect against a wider range of diseases. This has led to an increase in the development and availability of combination vaccines, which offer protection against multiple diseases in a single shot. Another trend in the market is the increasing use of vaccines among adults, as well as children. This is due to a growing awareness of the importance of vaccination throughout life, as well as the increasing availability of vaccines that are specifically designed for adults.

Local special circumstances: United Arab Emirates has a relatively high population density, which can make it easier for communicable diseases to spread. Additionally, the country has a large expatriate population, which can increase the risk of disease transmission. These factors have contributed to a growing demand for vaccines in the country.

Underlying macroeconomic factors: The United Arab Emirates has a strong economy, which has contributed to the growth of the Other Vaccines market in the country. Additionally, the government has been investing in healthcare infrastructure and services, which has led to an increase in the availability of vaccines. Finally, the country's strategic location has made it an important hub for the distribution of vaccines throughout the region.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.